DEVELOPMENT OF ASSAYS FOR DETECTING DRG-DRUG INTERACTION EFFECTS AND DS (Q2035312)

From EU Knowledge Graph
Revision as of 08:41, 2 November 2020 by DG Regio (talk | contribs) (‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement)
Jump to navigation Jump to search
Project Q2035312 in Italy
Language Label Description Also known as
English
DEVELOPMENT OF ASSAYS FOR DETECTING DRG-DRUG INTERACTION EFFECTS AND DS
Project Q2035312 in Italy

    Statements

    country
    Italy
    0 references
    EU contribution
    329,141.41 Euro
    0 references
    budget
    658,282.82 Euro
    0 references
    co-financing rate
    50.0 percent
    0 references
    start time
    13 December 2016
    0 references
    expected end time
    6 July 2019
    0 references
    beneficiary name (string)
    FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
    0 references
    GENECHRON S.R.L.
    0 references
    beneficiary
    Q271004
    0 references
    Q282209
    0 references
    programme
    Lazio - ERDF
    0 references
    coordinate location

    41°53'35.95"N, 12°28'58.55"E
    0 references
    summary
    IL PROGETTO DIHETOX NASCE DALL'ESIGENZA DI IDENTIFICARE E VALIDARE BIOMARCATORI A RNA (MIRNA O MRNA) IN GRADO DI RILEVARE PRECOCEMENTE LA PRESENZA DI DANNO AL FEGATO INDOTTO DA FARMACI O DRUG-INDUCED LIVER INJURY (DILI) (Italian)
    0 references
    THE DIETOX PROJECT STEMS FROM THE NEED TO IDENTIFY AND VALIDATE BIOMARKERS FOR RNA (MIRNA OR MRNA) ABLE TO DETECT EARLY LIVER DAMAGE CAUSED BY DRUGS OR DRUG-INDUSTRY (DILI) (English)
    0 references

    Identifiers

    Italian Unique Project Code
    F87H18000400007
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q2035312&oldid=7646450"